MiNK Therapeutics
(NASDAQ) INKT
MiNK Therapeutics Financials at a Glance
Market Cap
$49.38M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.36M
EPS (TTM)
$-3.03
P/E Ratio
-3.47
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$10.71
Volume
1,061
Open
$11.21
Price
$10.71
Volume
1,061
Open
$11.21
Previous Close
$10.71
Daily Range
$10.63 - $11.26
52-Week Range
$6.34 - $76.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$10.71
Volume
1,061
Open
$11.21
Previous Close
$10.71
Daily Range
$10.63 - $11.26
52-Week Range
$6.34 - $76.00
INKT News
INKT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MiNK Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Jennifer S. Buell, PhD
Website
www.minktherapeutics.comHeadquarters
New York City, NY 10010, US
INKT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-7%
Return on Assets
-83%
Earnings Yield
-28.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$49.38M
Shares Outstanding
4.69M
Volume
1.06K
Short Interest
0.00%
Avg. Volume
291.73K
Financials (TTM)
Gross Profit
$215.44K
Operating Income
$10.65M
EBITDA
$10.57M
Operating Cash Flow
$9.56M
Capital Expenditure
$4.00
Free Cash Flow
$9.56M
Cash & ST Invst.
$4.58M
Total Debt
$4.92M
MiNK Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$43.65K
+30.3%
Gross Margin
0.00%
N/A
Market Cap
$49.38M
N/A
Market Cap/Employee
$2.15M
N/A
Employees
23
N/A
Net Income
$2.89M
-59.8%
EBITDA
$2.84M
-63.1%
Quarterly Fundamentals
Net Cash
$8.56M
+398.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$5.73M
N/A
Return on Assets
-82.57%
N/A
Return on Invested Capital
-7.47%
N/A
Free Cash Flow
$941.35K
+68.6%
Operating Cash Flow
$941.35K
+68.6%